Education
About Us
Working with TipRanks
Follow Us
NanoViricides (NNVC)
:NNVC
Total Valuation
NanoViricides has a market cap or net worth of $20.80M. The enterprise value is $16.71M.
Market Cap$20.80M
Enterprise Value$16.71M
Share Statistics
NanoViricides has 15,641,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding15,641,000
Owned by Insiders6.73%
Owned by Institutions0.10%
Financial Efficiency
NanoViricides’s return on equity (ROE) is -0.72 and return on invested capital (ROIC) is -74.29%.
Return on Equity (ROE)-0.72
Return on Assets (ROA)-0.65
Return on Invested Capital (ROIC)-74.29%
Return on Capital Employed (ROCE)-0.74
Revenue Per Employee0.00
Profits Per Employee-1.18M
Employee Count7
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of NanoViricides is -2.65. NanoViricides’s PEG ratio is 0.49.
PE Ratio-2.65
PS Ratio―
PB Ratio1.92
Price to Fair Value1.92
Price to FCF-3.39
Price to Operating Cash Flow-3.48
PEG Ratio0.49
Income Statement
In the last 12 months, NanoViricides had revenue of 0.00 and earned -8.29M in profits. Earnings per share was -0.70.
Revenue0.00
Gross Profit-759.01K
Operating Income-8.52M
Pretax Income-8.29M
Net Income-8.29M
EBITDA-7.76M
Earnings Per Share (EPS)-0.70
Cash Flow
In the last 12 months, operating cash flow was -8.21M and capital expenditures -189.56K, giving a free cash flow of -8.40M billion.
Operating Cash Flow-8.21M
Free Cash Flow-8.40M
Free Cash Flow per Share-0.54
Dividends & Yields
NanoViricides pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.89
52-Week Price Change16.07%
50-Day Moving Average1.26
200-Day Moving Average1.50
Relative Strength Index (RSI)55.63
Average Volume (3m)127.49K
Important Dates
NanoViricides upcoming earnings date is Nov 24, 2025, TBA Not Confirmed.
Last Earnings DateNov 18, 2024
Next Earnings DateNov 24, 2025
Ex-Dividend Date―
Financial Position
NanoViricides as a current ratio of 3.66, with Debt / Equity ratio of 0.00%
Current Ratio3.66
Quick Ratio3.66
Debt to Market Cap0.00
Net Debt to EBITDA0.62
Interest Coverage Ratio0.00
Taxes
In the past 12 months, NanoViricides has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
NanoViricides EV to EBITDA ratio is -2.21, with an EV/FCF ratio of -2.65.
EV to Sales0.00
EV to EBITDA-2.21
EV to Free Cash Flow-2.65
EV to Operating Cash Flow-2.72
Balance Sheet
NanoViricides has $3.96M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$3.96M billion.
Cash & Marketable Securities$3.96M
Total Debt$0.00
Net Cash-$3.96M
Net Cash Per Share-$0.25
Tangible Book Value Per Share$0.94
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for NanoViricides is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast10.23%